Updates

Press Release: Texas Launches Largest Publicly-Funded Psychedelic Research Initiative in History with $50 Million Investment in Ibogaine

Texas becomes the first state in the nation to invest in drug development trials for ibogaine, launching the largest publicly-funded psychedelic research initiative in history and offering new hope for those suffering from substance use, trauma, and brain injury.

Press Release: Veterans Exploring Treatment Solutions (VETS) Leads Legislative Day of Action in Support of AB 1103 at California State Capitol

VETS Advocacy Campaign Expands to California as Efforts for Access to Life-Changing Mental Health Treatments Continue

Press Release: Veterans Exploring Treatment Solutions (VETS) Grant Recipients Participate in Groundbreaking Stanford Study on Ibogaine Treatment for PTSD and TBI

Press Release: Veterans Exploring Treatment Solutions (VETS) Applauds Texas on Passing the Largest Publicly Funded Psychedelic Research Investment in U.S. History

VETS celebrates the passage of the Texas Ibogaine Initiative—landmark legislation that allocates $100 million in public and private funding to study ibogaine-assisted therapy for PTSD, addiction, and TBI. This historic investment, driven in large part by VETS’ advocacy, positions Texas as a national leader in psychedelic research and veteran mental health care.

Press Release: Veterans Exploring Treatment Solutions (VETS) Leads Legislative Day of Action on March 18, 2025 in Support of Texas Ibogaine Initiative

The Legislative Day of Action aims to educate legislators on the transformative potential of ibogaine-assisted therapy for veterans struggling with OUD, co-occurring SUD, and neurological or mental health conditions, as well as address the critical issue that service members must travel internationally to access these treatments.